Prostate cancer is the most common cancer among American men, and it also has one of the highest survival rates — over 97% at 5 years for all stages combined. For life insurance purposes, this means prostate cancer survivors are often treated more favorably than survivors of other cancers. Many men qualify for standard or near-standard rates, especially when the cancer was caught early and treated successfully.

Here's what insurers look at and what you can realistically expect.

How Insurers Evaluate Prostate Cancer

Underwriters assess prostate cancer applications using a combination of clinical and pathological factors:

  • Gleason score — This is the most important pathological factor. Gleason 6 (low grade) is viewed most favorably. Gleason 7 is moderate risk. Gleason 8–10 is high grade and results in higher ratings or declines.
  • PSA level at diagnosis and post-treatment — A low PSA at diagnosis and undetectable PSA after treatment (PSA nadir) are strong positive indicators. Rising PSA post-treatment signals potential recurrence and is a significant concern for underwriters.
  • Stage at diagnosis — Localized (Stage I/II) prostate cancer confined to the gland is viewed very favorably. Regional spread (Stage III) requires longer waiting periods. Metastatic (Stage IV) significantly limits standard coverage options.
  • Treatment type — Prostatectomy (surgical removal), radiation therapy, and active surveillance are all considered. Successful prostatectomy with clear margins is often viewed most favorably.
  • Time since treatment — More time with a stable, undetectable PSA improves your application considerably.
  • Age at diagnosis — Younger men diagnosed with prostate cancer are viewed more cautiously than older men, as it may indicate a more aggressive form.

Waiting Periods and Rate Expectations

Gleason 6, Stage I/II (Low Grade, Localized)

This is the most favorable scenario for life insurance. Many insurers will consider applications 1–2 years after treatment completion. Table ratings of Table 2–3 are common initially. After 3–5 years with an undetectable PSA, standard rates are often achievable. Some carriers are particularly favorable for low-grade localized prostate cancer — an independent broker can identify which ones.

Gleason 7, Stage II

Intermediate grade requires a bit more caution from underwriters. Waiting periods of 2–3 years are typical. Table ratings of Table 3–5 are common. After 5 years with stable PSA, the picture improves significantly.

Gleason 8–10 or Stage III

High-grade or locally advanced prostate cancer requires longer waiting periods — typically 5+ years. Table ratings are higher, and some carriers may decline entirely. After 7–10 years cancer-free with consistently undetectable PSA, more options become available.

Stage IV (Metastatic)

Standard life insurance is generally not available for active or recently treated metastatic prostate cancer. Guaranteed issue policies (no health questions, limited coverage up to $25,000) are the primary option, with a 2-year waiting period before full benefits apply.

What About Active Surveillance?

Active surveillance — monitoring low-grade prostate cancer without immediate treatment — is increasingly common and medically appropriate for many men with Gleason 6, Stage I disease. For life insurance purposes, active surveillance does complicate underwriting because the cancer is technically still present. Some insurers will still consider applications; others require treatment to have been completed. An independent broker familiar with this nuance can identify the most favorable carriers.

The Role of PSA Testing in Your Application

PSA (prostate-specific antigen) test results will be central to your underwriting. Post-treatment PSA trajectory matters enormously:

  • Undetectable PSA (typically below 0.1 ng/mL after prostatectomy) is the strongest possible signal and supports favorable underwriting.
  • Stable low PSA after radiation therapy is also viewed positively.
  • Rising PSA post-treatment (biochemical recurrence) is a serious concern and will likely result in declines or postponement from most standard insurers until the situation is stabilized.

Have your most recent PSA results readily available when you apply.

How to Strengthen Your Application

  • Organize your records. Pathology reports (including Gleason score), surgical notes, radiation treatment records, and a timeline of PSA results post-treatment are all important.
  • Stay current with PSA monitoring. Regular PSA testing on your oncologist's recommended schedule — with consistently stable or undetectable results — is the single most powerful thing you can bring to an underwriter.
  • Optimize other health factors. Non-smoker status, healthy weight, good blood pressure, and no other major conditions help offset the cancer history.
  • Work with an independent broker. Prostate cancer underwriting varies widely between carriers. Some are considerably more favorable for specific Gleason scores and stages. An independent broker who specializes in impaired risk life insurance can match you with the right carrier and save you significant money.
  • Disclose fully. Never omit cancer history on an application. A denied claim because of non-disclosure would leave your family without the protection you intended to provide.

If Standard Coverage Isn't Available Yet

  • Guaranteed issue life insurance — No medical questions, anyone qualifies. Coverage is limited ($5,000–$25,000), premiums are higher relative to coverage, and a 2-year graded benefit period applies. A viable temporary option while you wait for standard coverage eligibility.
  • Simplified issue life insurance — Fewer health questions, no exam, coverage up to $500K with some carriers. A practical bridge policy if you're in the early years post-treatment.
  • Group life insurance through your employer — Employer-sponsored group coverage typically has no medical underwriting. Maximize this benefit if it's available to you — it's often your best option during the waiting period.

How Much Coverage Do You Need?

Coverage needs are driven by your income, debts, and dependents — not your health history. Use our Life Insurance Calculator to get a personalized estimate based on your situation.

Bottom Line

Prostate cancer survivors — particularly those with low-grade, localized disease and a stable post-treatment PSA — have strong life insurance options. Even men with more advanced cases often find that coverage becomes accessible after several years of clean follow-up. The key is knowing which insurers are most favorable for your specific situation, presenting your medical history clearly, and not assuming you'll be turned down before you've actually checked.